Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HoMING: Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
NCT04363983Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Primary completion
- Jan 2031
- Countries
- 1
01
Overview
Open-label trial (10 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Overall Survival. Started Jan 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04363983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363983.